Related Experiment Video
Updated: May 21, 2026

07:10
Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
Piecewise HIV virus dynamic model with CD4(+) T cell count-guided therapy: I
Sanyi Tang1, Yanni Xiao, Ning Wang
1College of Mathematics and Information Science, Shaanxi Normal University, Xi'an 710062, PR China. sanyitang219@hotmail.com
Journal of Theoretical Biology
|June 5, 2012
Summary
Structured treatment interruptions (STIs) for HIV management show promise. CD4(+) T cell count-guided STIs, when carefully individualized, can maintain safe levels and stabilize viral dynamics, explaining past study inconsistencies.
Area of Science:
- Virology
- Mathematical Modeling
- Immunology
Background:
- Structured treatment interruptions (STIs) are proposed for HIV management but yield inconsistent clinical results.
- Previous studies on STIs have not reached a consensus on their efficacy and safety.
- Understanding the dynamic behavior of HIV during STIs is crucial for optimizing patient outcomes.
Purpose of the Study:
- To quantitatively evaluate CD4(+) T cell count-guided STI strategies for HIV management.
- To explain the controversial conclusions from different clinical studies on STIs.
- To investigate the dynamic behaviors of HIV under various STI protocols.
Main Methods:
- Utilized piecewise HIV virus dynamic models for quantitative analysis.
- Simulated STI strategies with single and threshold window controls for CD4(+) T cell counts.
- Analyzed the impact of upper and lower threshold values on CD4(+) T cell dynamics and treatment durations.
Main Results:
- CD4(+) T cell counts can be maintained above safe levels using STI with threshold controls.
- Simulations demonstrated that CD4(+) T cell counts can fluctuate or stabilize based on threshold settings.
- Threshold policy control enables stabilization of CD4(+) T cell counts at desired levels.
- Treatment durations (drug-on/drug-off) are highly sensitive to threshold choices.
Conclusions:
- CD4(+) T cell count-guided STIs can effectively maintain immune cell counts.
- Individualizing STI strategies by carefully selecting CD4(+) T cell count thresholds is critical for successful HIV management.
- Threshold sensitivity explains the failure rates associated with fixed-schedule or frequent-switch STI strategies.
